Tingyu Zhao, Hui Zhao, Xiao Zhang, Xingyu Jiang, Qi Liang, Siqi Ni, Yi Jiao, Jiamei Yu, Jianghong Dai, Mulong Du, Lingxiang Liu
{"title":"营养、炎症状态和睡眠质量对癌症幸存者死亡率的综合影响。","authors":"Tingyu Zhao, Hui Zhao, Xiao Zhang, Xingyu Jiang, Qi Liang, Siqi Ni, Yi Jiao, Jiamei Yu, Jianghong Dai, Mulong Du, Lingxiang Liu","doi":"10.1186/s12885-024-13181-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cancer survivors face many challenges in long-term health management, including malnutrition, systemic inflammation, and sleep issues, which significantly affect their survival and quality of life.</p><p><strong>Methods: </strong>A prospective cohort study was derived from the National Health and Nutrition Examination Survey from 2005-2018 harboring 1,908 cancer survivors (weighted population, 11,453,293), of whom 688 deaths (220 from cancer mortality, 468 from non-cancer mortality). The Advanced Lung Cancer Inflammation Index (ALI) was used as a measure of nutritional status and systemic inflammation in cancer patients. Weighted multivariable Cox proportional hazards regression models were utilized to explore the independent and combined effects of ALI and sleep quality on mortality outcomes.</p><p><strong>Results: </strong>The participants with a high ALI were more likely to be female, aged 40 to 64 years, non-Hispanic white, and have a higher BMI. We observed that elevated ALI levels were associated with decreased risks of all-cause mortality (Hazard ratio [HR] = 0.601, 95% Confidence interval [CI] = 0.521-0.695, P < 0.001), cancer-specific mortality (HR = 0.659, 95% CI = 0.497-0.870, P = 3.34 × 10<sup>-3</sup>) and non-cancer-specific mortality (HR = 0.579, 95% CI = 0.478-0.701, P < 0.001). Similarly, better sleep quality (e.g., without sleep troubles) was associated with lower risks of all-cause mortality (HR = 0.761, 95% CI = 0.620-0.933, P = 8.79 × 10<sup>-3</sup>) and non-cancer-specific mortality (HR = 0.713, 95% CI = 0.572-0.890, P = 2.80 × 10<sup>-3</sup>). Notably, the joint analysis showed that cancer survivors with higher ALI levels and better sleep quality (e.g., standard sleep duration) had the lowest risks of all-cause (HR = 0.468, 95% CI = 0.352-0.622, P < 0.001), cancer-specific mortality (HR = 0.631, 95% CI = 0.333-0.672, P = 7.59 × 10<sup>-3</sup>) and non-cancer-specific mortality (HR = 0.440, 95% CI = 0.315-0.615, P < 0.001).</p><p><strong>Conclusions: </strong>This study suggests that better nutritional and inflammatory status, combined with good sleep quality, may contribute to improved survival among cancer survivors. These results underscore the potential clinical importance of integrating nutritional and sleep quality assessments into the long-term care of cancer survivors to enhance their overall prognosis.</p>","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":"24 1","pages":"1456"},"PeriodicalIF":3.4000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Combined effects of nutrition, inflammatory status, and sleep quality on mortality in cancer survivors.\",\"authors\":\"Tingyu Zhao, Hui Zhao, Xiao Zhang, Xingyu Jiang, Qi Liang, Siqi Ni, Yi Jiao, Jiamei Yu, Jianghong Dai, Mulong Du, Lingxiang Liu\",\"doi\":\"10.1186/s12885-024-13181-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Cancer survivors face many challenges in long-term health management, including malnutrition, systemic inflammation, and sleep issues, which significantly affect their survival and quality of life.</p><p><strong>Methods: </strong>A prospective cohort study was derived from the National Health and Nutrition Examination Survey from 2005-2018 harboring 1,908 cancer survivors (weighted population, 11,453,293), of whom 688 deaths (220 from cancer mortality, 468 from non-cancer mortality). The Advanced Lung Cancer Inflammation Index (ALI) was used as a measure of nutritional status and systemic inflammation in cancer patients. Weighted multivariable Cox proportional hazards regression models were utilized to explore the independent and combined effects of ALI and sleep quality on mortality outcomes.</p><p><strong>Results: </strong>The participants with a high ALI were more likely to be female, aged 40 to 64 years, non-Hispanic white, and have a higher BMI. We observed that elevated ALI levels were associated with decreased risks of all-cause mortality (Hazard ratio [HR] = 0.601, 95% Confidence interval [CI] = 0.521-0.695, P < 0.001), cancer-specific mortality (HR = 0.659, 95% CI = 0.497-0.870, P = 3.34 × 10<sup>-3</sup>) and non-cancer-specific mortality (HR = 0.579, 95% CI = 0.478-0.701, P < 0.001). Similarly, better sleep quality (e.g., without sleep troubles) was associated with lower risks of all-cause mortality (HR = 0.761, 95% CI = 0.620-0.933, P = 8.79 × 10<sup>-3</sup>) and non-cancer-specific mortality (HR = 0.713, 95% CI = 0.572-0.890, P = 2.80 × 10<sup>-3</sup>). Notably, the joint analysis showed that cancer survivors with higher ALI levels and better sleep quality (e.g., standard sleep duration) had the lowest risks of all-cause (HR = 0.468, 95% CI = 0.352-0.622, P < 0.001), cancer-specific mortality (HR = 0.631, 95% CI = 0.333-0.672, P = 7.59 × 10<sup>-3</sup>) and non-cancer-specific mortality (HR = 0.440, 95% CI = 0.315-0.615, P < 0.001).</p><p><strong>Conclusions: </strong>This study suggests that better nutritional and inflammatory status, combined with good sleep quality, may contribute to improved survival among cancer survivors. These results underscore the potential clinical importance of integrating nutritional and sleep quality assessments into the long-term care of cancer survivors to enhance their overall prognosis.</p>\",\"PeriodicalId\":9131,\"journal\":{\"name\":\"BMC Cancer\",\"volume\":\"24 1\",\"pages\":\"1456\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-11-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12885-024-13181-x\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12885-024-13181-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:癌症幸存者在长期健康管理中面临许多挑战,包括营养不良、全身炎症和睡眠问题,这些问题严重影响了他们的生存和生活质量:一项前瞻性队列研究来自于2005-2018年的美国国家健康与营养调查,共收集了1,908名癌症幸存者(加权人口为11,453,293人),其中688人死亡(220人死于癌症,468人死于非癌症)。晚期肺癌炎症指数(ALI)被用来衡量癌症患者的营养状况和全身炎症。利用加权多变量考克斯比例危险回归模型探讨了ALI和睡眠质量对死亡率结果的独立影响和综合影响:结果:ALI水平较高的参与者更有可能是女性,年龄在40至64岁之间,非西班牙裔白人,体重指数较高。我们观察到,ALI水平升高与全因死亡率(危险比[HR] = 0.601,95% 置信区间[CI] = 0.521-0.695,P -3)、非癌症特异性死亡率(HR = 0.579,95% CI = 0.478-0.701,P -3)和非癌症特异性死亡率(HR = 0.713,95% CI = 0.572-0.890,P = 2.80 × 10-3)风险降低有关。值得注意的是,联合分析表明,ALI水平较高且睡眠质量较好(如标准睡眠时间)的癌症幸存者的全因死亡率(HR = 0.468,95% CI = 0.352-0.622,P -3)和非癌症特异性死亡率(HR = 0.440,95% CI = 0.315-0.615,P 结论:这项研究表明,改善营养和炎症状态,再加上良好的睡眠质量,可能有助于提高癌症幸存者的生存率。这些结果强调了将营养和睡眠质量评估纳入癌症幸存者长期护理以改善其整体预后的潜在临床重要性。
Combined effects of nutrition, inflammatory status, and sleep quality on mortality in cancer survivors.
Background: Cancer survivors face many challenges in long-term health management, including malnutrition, systemic inflammation, and sleep issues, which significantly affect their survival and quality of life.
Methods: A prospective cohort study was derived from the National Health and Nutrition Examination Survey from 2005-2018 harboring 1,908 cancer survivors (weighted population, 11,453,293), of whom 688 deaths (220 from cancer mortality, 468 from non-cancer mortality). The Advanced Lung Cancer Inflammation Index (ALI) was used as a measure of nutritional status and systemic inflammation in cancer patients. Weighted multivariable Cox proportional hazards regression models were utilized to explore the independent and combined effects of ALI and sleep quality on mortality outcomes.
Results: The participants with a high ALI were more likely to be female, aged 40 to 64 years, non-Hispanic white, and have a higher BMI. We observed that elevated ALI levels were associated with decreased risks of all-cause mortality (Hazard ratio [HR] = 0.601, 95% Confidence interval [CI] = 0.521-0.695, P < 0.001), cancer-specific mortality (HR = 0.659, 95% CI = 0.497-0.870, P = 3.34 × 10-3) and non-cancer-specific mortality (HR = 0.579, 95% CI = 0.478-0.701, P < 0.001). Similarly, better sleep quality (e.g., without sleep troubles) was associated with lower risks of all-cause mortality (HR = 0.761, 95% CI = 0.620-0.933, P = 8.79 × 10-3) and non-cancer-specific mortality (HR = 0.713, 95% CI = 0.572-0.890, P = 2.80 × 10-3). Notably, the joint analysis showed that cancer survivors with higher ALI levels and better sleep quality (e.g., standard sleep duration) had the lowest risks of all-cause (HR = 0.468, 95% CI = 0.352-0.622, P < 0.001), cancer-specific mortality (HR = 0.631, 95% CI = 0.333-0.672, P = 7.59 × 10-3) and non-cancer-specific mortality (HR = 0.440, 95% CI = 0.315-0.615, P < 0.001).
Conclusions: This study suggests that better nutritional and inflammatory status, combined with good sleep quality, may contribute to improved survival among cancer survivors. These results underscore the potential clinical importance of integrating nutritional and sleep quality assessments into the long-term care of cancer survivors to enhance their overall prognosis.
期刊介绍:
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.